Silver Book Fact

Drug resistant infections cost $16.6 – $26 billion to US healthcare system annually

Drug-resistant infections cost the U.S. healthcare system between $16.6 and $26 billion in extra costs each year.

Roberts, Rebecca R., Bala Hota, Ibrar Ahmad, R. Douglas Scott, Susan D. Foster, Fauzia Abbasi, Shari Schabowski, Linda M. Kampe, Ginerva G. Ciavarella, Mark Supino, Jeremy Naples, Ralph Cordell, Stuart B. Levy, and Robert A. Weinstein. Hospital and Societal Costs of Antimicrobial-Resistant Infections in a Chicago Teaching Hospital: Implicatons for antibiotic stewardship. Clin Infect Dis. 2009; 49(8): 1175-84. http://cid.oxfordjournals.org/content/49/8/1175.full

Reference

Title
Hospital and Societal Costs of Antimicrobial-Resistant Infections in a Chicago Teaching Hospital: Implicatons for antibiotic stewardship
Publication
Clin Infect Dis
Publication Date
2009
Authors
Roberts, Rebecca R., Bala Hota, Ibrar Ahmad, R. Douglas Scott, Susan D. Foster, Fauzia Abbasi, Shari Schabowski, Linda M. Kampe, Ginerva G. Ciavarella, Mark Supino, Jeremy Naples, Ralph Cordell, Stuart B. Levy, and Robert A. Weinstein
Volume & Issue
Volume 49, Issue 8
Pages
1175-84
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • 1 in 4 inpatient pneumonia hospitalizations due to HAIs
    In one study, one in four inpatient pneumonia hospitalizations were from health-care-associated pneumonia.  
  • Mortality rate from hospital-acquired pneumonia
    The mortality rate for hospital-acquired pneumonia ranges from 38% to more than 70%.  
  • HAI Annual Cost
    Healthcare-associated infections in US hospitals cost $96–$147 billion annually.  
  • Drug-resistant infections increase length & cost of hospital stays
    Drug-resistant infections increase the length of hospital stays by more than 23% and the cost by close to 30%.  
  • Sepsis in hospitalized patients
    Hospitalized patients with sepsis who survived to 31 days experienced a 16.2% absolute increase in late mortality.